Compulsive behavior in the 5-HT2C receptor knockout mouse (Q44462730)

3 December 2017

Compulsive behavior in the 5-HT2C receptor knockout mouse (English)

1 reference

3 December 2017

0 references

4

Susan F Akana

1 reference

3 December 2017

3

Mary F Dallman

1 reference

3 December 2017

Jennifer M Chou-Green

series ordinal

1

1 reference

PubMed ID

12782219

3 December 2017

Todd D Holscher

series ordinal

2

1 reference

PubMed ID

12782219

3 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

3 December 2017

Physiology & Behavior

1 reference

3 December 2017

78

1 reference

3 December 2017

4-5

1 reference

3 December 2017

641-649

1 reference

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Molecular, pharmacological and functional diversity of 5-HT receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Serotonergic Function in Obsessive-Compulsive Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Spontaneous alternation behavior: An animal model for obsessive-compulsive disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Hoxb8 is required for normal grooming behavior in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Effects of serotonergic agents on food-restriction-induced hyperactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Motion sickness-induced pica in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Exploration of a hole-board matrix in nervous mutant mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Factors controlling measures of anxiety and responses to novelty in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Exploratory behavior models of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Application of 'nose-poke habituation' validation with post-trial diazepam- and cholecystokinin-induced hypo- and hypermnesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

Intraventricular neuropeptide Y decreases need-induced sodium appetite and increases pica in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2803%2900047-7

7 January 2021

10.1016/S0031-9384(03)00047-7

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

12782219